UK trials consultation, bilateral cataract surgery on one day, and no eye drops
Australia is likely to be watching with interest as a British company’s “pioneering” approach to cataract surgery is trialled in...
Australia is likely to be watching with interest as a British company’s “pioneering” approach to cataract surgery is trialled in...
Following the recent reclassification of repeated low-level red-light (RLRL) therapy in China, Eyerising International is hosting an online CPD event...
A gene therapy developed by scientists in the UK has been granted orphan drug designation by the US FDA and...
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited